Prevenotics specializes in AI-based endoscopic real-time diagnosis technology and patient management support, focusing on cancer prevention from the pre-cancer stage. Their software targets diseases starting from intestinal metaplasia, a pre-cancerous lesion, and is developed using Korea’s abundant endoscopy data.

Vision and Mission: Prevenotics aims to commercialize its AI solution for stomach cancer prevention and expand to other types of cancer prevention. Their mission is to build a zero cancer ecosystem, enhancing the accuracy of cancer diagnosis and providing active assistance in identifying pre-cancerous risks.

Noteworthy Points:

• Secured bridge investment from 500 Global, highlighting the importance of AI in healthcare.
• Led by CEO Jang Soo-yeon, with over 15 years of experience in global business development.
• Recently acquired a level 2 medical device certification for its endoscopic image analysis software.